Hyperparathyroidism – Analysis and Market Forecasts to 2019


Published on

The global hyperparathyroidism therapeutics market is forecast to grow to reach $2.6 billion by 2019. This moderate growth is primarily attributed to the increase in the hyperparathyroidism patient population and the expected launches of two novel drugs: CTAP101 and KAI-4169 IV.

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Hyperparathyroidism – Analysis and Market Forecasts to 2019

  1. 1. Category : Pharma & Healthcarewww.MarketResearchReports.com
  2. 2. Introduction to Report Launch Date: 31st October, 2012 Number of Pages: 70 Geography Coverage: Global Available Format: PDF Price For Single User License: USD 5,995 Price For Site User License: USD 11,990Price For Global User License: USD 17,985 Delivery Time: Within 24 Hours (During Working Days) www.MarketResearchReports.com
  3. 3. Scope of the Report:• Overview of hyperparathyroidism, including epidemiology, etiology, symptoms, diagnosis, pathophysiology, management and treatment guidelines.• Annualized hyperparathyroidism therapeutics market revenue, annual cost of therapy and forecast for eight years to 2019.• Pipeline analysis: Comprehensive data split across different phases, emerging trends and mechanisms of action under development, including calcium sensing receptor agonist, vitamin D pro-hormone, vitamin D receptor agonist and CYP24 enzyme inhibitor. www.MarketResearchReports.com
  4. 4. Scope of the Report:• Analysis of the current and future market competition in the global hyperparathyroidism therapeutics market.• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.• Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the hyperparathyroidism therapeutics market. www.MarketResearchReports.com
  5. 5. Reasons to Buy..• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.• Develop business strategies by understanding the trends shaping and driving the global hyperparathyroidism therapeutics market.• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global hyperparathyroidism therapeutics market in future.• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. www.MarketResearchReports.com
  6. 6. Reasons to Buy..• Identify emerging players with potentially strong product portfolios and create effective counter- strategies to gain a competitive advantage.• Track drug sales in the global hyperparathyroidism therapeutics market from 2011–2019.• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. www.MarketResearchReports.com
  7. 7. Report CoverageDisease OverviewCompetitive AssessmentOpportunity and Unmet NeedPipeline AssessmentClinical Trials MappingCurrent and Future PlayersLicensing and Partnership DealsSeven Major Markets Overview www.MarketResearchReports.com
  8. 8. Companies Covered:1. Amgen Inc.2. Abbott Laboratories3. Cytochroma Inc.4. KAI Pharmaceuticals Inc. www.MarketResearchReports.com
  9. 9. How To Buy This Report?Visit following URL to see Table of Content andpurchase this publication:http://www.marketresearchreports.com/globaldata/hyperparathyroidism-%E2%80%93-analysis-and-market-forecasts-2019 About Market Research ReportsMarket Research Reports provides a customized setof reports from reputed Publishers, built on theintelligence available within organizations andleverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +91-8762746600 www.MarketResearchReports.com